Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on UK Healthcare Gazette.
Press releases published on July 11, 2025
PitPat Launches July Week2 Open Trials 10km: Bringing Global Runners Together for Glory, Challenge, and Real Rewards
EIN Presswire
·
July 11, 2025
HOUSTON, TX, UNITED STATES, July 11, 2025 /EINPresswire.com/ -- As the world’s leading virtual competition platform, PitPat is dedicated to breaking the barriers of distance and time through technology and innovation. By making running, cycling, rowing, …
MethodSense Launches Elsa & AI Resource Center to Help Medical Device Companies Navigate the FDA’s AI Era
EIN Presswire
·
July 11, 2025
MORRISVILLE, NC, UNITED STATES, July 11, 2025 /EINPresswire.com/ -- MethodSense, a regulatory consulting and technology firm with more than 25 years of experience guiding medical device companies through the FDA and onto commercial markets, today …
VSY Biotechnology Enters the Japanese Market!
EIN Presswire
·
July 11, 2025
LEINFELDEN-ECHTERDINGEN, GERMANY, July 11, 2025 /EINPresswire.com/ -- Sinusoidal Trifocal Technology® developed by VSY Biotechnology GmbH has been officially approved in Japan. Non-toric and toric IOLs produced with this innovative technology, which …
WISE SpA first to achieve MDR certification of cortical strip for Neuromonitoring
EIN Presswire
·
July 11, 2025
The WISE Cortical Strip (WCS®) is the first cortical strip for Intraoperative Neurophysiological Monitoring (IONM) to achieve CE mark under MDR (1) MILAN, ITALY, July 11, 2025 /EINPresswire.com/ -- WISE SpA, a pioneering medical device company …
e-therapeutics reduziert Risiken im klinischen Verfahren für GalOmic-Kandidaten ETX-312 dank positiver Ergebnisse in der vorklinischen Phase
GlobeNewswire
·
July 11, 2025
ETX-312 wurde in GLP-konformen Toxikologiestudien in überhöhten Dosierungen gut vertragen GMP-konforme Herstellung einer Charge für klinische Studien erfolgreich abgeschlossen Auf Kurs für die Einreichung bei der CTA im vierten Quartal 2025 LONDON, July 11 …
e-therapeutics sécurise le développement clinique de son candidat GalOmic ETX-312 grâce à des données non cliniques positives
GlobeNewswire
·
July 11, 2025
ETX-312 bien toléré à des doses élevées lors d’études de toxicologie conformes aux normes BPL Fabrication du lot destiné à l’essai clinique achevée avec succès conformément aux normes BPF Soumission de la demande d’autorisation d’essai clinique en bonne …